Menthol solutions of drugs

Details for Australian Patent Application No. 2004212989 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Flashner-Barak, Moshe; Lerner, Itzhak E.; Rosenberger, Vered; Moldavski, Naomi

Agent Shelston IP

Pub. Number AU-A-2004212989

PCT Pub. Number WO2004/073686

Priority 60/449,246 20.02.03 US

Filing date 17 February 2004

Wipo publication date 2 September 2004

International Classifications

A61K 009/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

Event Publications

15 September 2005 PCT application entered the National Phase

  PCT publication WO2004/073686 Priority application(s): WO2004/073686

28 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212990-Motion detector for controlling electrosurgical output

2004212985-Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists